Xofluza 40 mg Filmtabletten

Recall | Medicines | 17/05/2022

The marketing authorisation holder informed its customers on May 16, 2022, that batch B8159N01 of the medicinal product "Xofluza 40 mg Filmtabletten" is recalled due to an incorrect expiry date (11.2023 instead of 06.2023). A risk for patients is not expected due to sufficiently available stability data.


Name of the medicinal product Xofluza 40 mg Filmtabletten
Marketing authorisation number(s) EU/1/20/1500/002
CIP code 4987799
Marketing authorisation holder Roche Registration GmbH
Batch number(s) B8159N01
Expiry date 11/30/2023
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-3863

Further inquiry note